We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Our writer Ken Hall evaluates two defensive dividend payers in the FTSE 100 that he thinks investors should consider buying ...

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Nairobi — UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025. The rebrand comes after GSK transferred its consumer health business to Haleon to ...

British investment firm SV Health Investors has secured $250 million to go toward the development of first-in-class ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein. The ...

Cumbria Health has appointed Ed Tallis as its new chair of the board of directors. Mr Tallis will take on the role in April, succeeding Ian Johnson.

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...